PARP Inhibition After Preoperative Chemotherapy in Patients with Triple Negative Breast Cancer on ER/PR, HER2 Negative with Known BRCA 1/2 Mutations: Hoosier Oncology Group BRE09146

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/10 → 1/1/16

Funding

  • Hoosier Oncology Group (HOG)